Meeting/Event Information

MSHP 67th Annual Meeting


July 23, 2020
8:00 AM - 5:00 PM
Add to Calendar


VIRTUAL! (Live, Online)
Your Computer!

We are going virtual!

Due to the COVID-19 situation, MSHP has decided to offer our Annual Meeting as a live, online, virtual experience.  Join us on July 23 and 24, 2020, from your home or work computer.  This meeting will offer a total of 10 hours of C.E. programming, including 3 hours of substance abuse/addiction topics.  Also, we will once again offer the Mississippi Consultant Pharmacist certification (participant must attend the 1 hour of consultant law session).

We will be using Zoom Webinar for this meeting.  It is recommended that you use a computer, laptop, or tablet device for optimal experience, connectivity and interaction.

List of topics and presentors:  click here!

Paper (print) registration form:  click here!

Program schedule

Thursday, July 23, 2020

8:30 – 9:30 am 

Implementation of Comprehensive, Pharmacy-led, Transitions of Care Services at a Community Hospital: Lessons Learned

Trey Crumby, PharmD, Anastasia Jenkins, PharmD


  1. List patient outcomes for various strategies managing patient care transitions into, within, and out of an inpatient care facility.
  2. Discuss ideal roles for pharmacists as presented in the literature for managing patient care transitions.
  3. Identify strategies to extend pharmacy department presence in the care transitions process.
  4. Describe one facility’s experience in developing an outpatient pharmacy program in order to more thoroughly participate in the discharge process.


9:45 – 10:45 am

No Stewardship Pharmacist, No Problem!

Katie Schipper, PharmD, BCCCP


  1. Describe antimicrobial stewardship requirements for hospitals.
  2. Discuss ways to meet antimicrobial stewardship requirements for hospitals.
  3. Evaluate ways to implement stewardship activities in hospitals without dedicated stewardship personnel.


11:00 am – 12:00 pm

Opioid Utilization Pearls

Thomas Webb, PharmD, BCPS


  1. Discuss risks of opioid agents used to treat pain.
  2. Select an appropriate agent for treatment of opioid use disorder.
  3. Assess if a patient would benefit from having access to a naloxone product.
  4. Develop a treatment plan for resolving opioid-induced constipation.


1:30 – 2:30 pm

NMMC Specialty Pharmacy: Our Journey

Amanda Pitts Summers, PharmD


  1. Discuss the basic process in developing a specialty pharmacy service.
  2. Outline the process of specialty pharmacy accreditation.
  3. Discuss patient care pearls within the specialty pharmacy setting.


2:45 – 3:45 pm

The Pharmacists Primer for OTC Treatment Options for Common Skin Diseases

Robert T. Brodell, MD, FAAD


  1. Discuss the nature of Category 1 GRASE ingredients (Generally Recognized as Safe and Effective)
  2. Summarize effective advice for treatment of common skin conditions that can be treated effectively over the counter.


Friday, July 24, 2020

8:30 – 9:30 am

Consultant Pharmacy Law Update 2020

Randy Pittman, PharmD


  1. Discuss updated CMS Mega Rule requirements for long-term care.
  2. List current CASPER data from CMS related to psychotropic medication use in long-term care.
  3. Discuss current issues related to consultant pharmacy practice.


9:45 – 10:45 am

The Cost of Caring: Recognizing Compassion Fatigue and Building Resilience

Lindsey Lepard, PharmD, BCPPS


  1. Define compassion fatigue and who is at risk.
  2. Identify the signs and symptoms of compassion fatigue.
  3. Describe methods to manage compassion fatigue.


11:00 am – 12:00 pm

ASHP Opioid Task Force: Outcomes and Actions

David Chen, RPh, MBA


  1. Discuss the opioid epidemic in the United States.
  2. Describe the outcomes of the ASHP Opioid Task Force and its application to pharmacy practice.
  3. Compare how pharmacists are addressing the opioid epidemic and opportunities to improve patient care.

1:30 – 2:30 pm

An Update on Medications, Equipment, and Services Available Over the Counter and at Retail Pharmacies

Shanna Whitwell, PharmD


  1. Identify medications that are now available over the counter.
  2. List equipment and updates to products that are available without a prescription.
  3. Discuss tests and services that can be provided at a retail pharmacy.


2:45 – 3:45 pm

The Role of Psychedelic Drugs and Kratom in Mental Illness and Addiction

Katie S. Collier, PharmD, BCPS and Grant H. Smith, PharmD


  1. Discuss the history, pharmacology, and medical literature of selected psychedelic drugs and Kratom.
  2. Summarize the laws and regulations of cannabis and Kratom.
  3. Discuss drug policies and the implications of drug prohibition



$75.00 Member ticket

$165.00 Non-Member: full meeting - includes membership through end of calendar year)

$50.00 Pharmacy Resident (MSHP Member)

$60.00 Pharmacy Resident (Non-Member)

$0.00 Pharmacy Student (MSHP Member)

$0.00 Pharmacy Student (Non-Member)

$250.00 Pharmacy Director particpating in Reverse Expo